A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
Summary
The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.
Detailed description
This is a study that aims to evaluate recruitment rates, feasibility, acceptability, and fidelity of Dialectical Behavior Therapy - Skills Training (DBT-ST) brief intervention. Study population will include participants who smoke and are undergoing treatment with curative intent for their cancer or are in remission. The study will include eight 60 minute sessions of DBT-ST and measurements of psychological states and smoking habits by interventionists. At follow-up participants will complete a survey on their intervention experience and ongoing use of DBT-ST. Interventionists will also complete a survey following each session to record time and materials use for future cost-effectiveness analysis. At follow-up, participants and interventionists will engage in a one-hour qualitative interview with a study team member.
Arms & interventions
- BehavioralDialectical Behavior Therapy -Skill Training brief intervention
A behavioral counseling approach for enhancing skills in emotion regulation, distress tolerance, and mindfulness
Outcome measures
Primary
Recruitment Rates
Ratio of patients enrolled in study to patients responding to advertisement or referred by providers, and ratio of patients enrolled to patients screened and potentially eligible for the study.
Time frame: Measured from the date the first patient responds to advertisement or is referred to the study by providers until the date the last patient group begins the first session of the intervention, assessed up to 100 weeks.
Feasibility of the DBT-ST brief intervention for cigarette smoking by patients with cancer
Rate of completion of the eight proposed sessions by participants
Time frame: Measured from the date the first patient group begins the first session of the intervention until the date the last patient group completes the eighth session of the intervention, assessed up to 100 weeks.
Acceptability of the DBT-ST brief intervention for cigarette smoking by patients with cancer
Quantitative (Likert scale) questions to assess patient experience of intervention
Time frame: For each patient group, measured at weeks 1 through 8 of the intervention and at 1 month follow-up, assessed up to 100 weeks.
Fidelity of the DBT-ST brief intervention for cigarette smoking by patients with cancer
Interventionist adherence to intervention manual will be assessed by having an independent reviewer select 50% of the audiotaped group sessions (the total depends on the number of groups) and complete a checklist of 25 intervention items (yes/no) to see whether the interventionist performed the item
Time frame: Measured beginning 1 month after the date of week 8 of the final patient group participating in the intervention, assessed up to 6 months.
Secondary
Cancer Patient Tobacco Use Questionnaire (C-TUQ)
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Difficulties in Emotion Regulation Scale-36 (DERS-36)
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Depression Anxiety Stress Scales-21 (DASS-21)
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Distress Tolerance Scale (DTS)
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Mindfulness Attention Awareness Scale (MAAS)
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Mental Adjustment to Cancer (MAC) Scale - Mini
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
DBT Ways of Coping Checklist (DBT-WCCL)
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Serious quit attempts
Time frame: Measured at baseline, week 5, week 8, and at 1 month follow-up, assessed up to 100 weeks.
Eligibility criteria
Study locations (2)
Atrium Health Levine Cancer
Charlotte, North Carolina, 28204
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157